{"database": "openregs", "table": "federal_register", "rows": [["2018-05659", "Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period", "Notice", "The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled \"Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Availability\" that appeared in the Federal Register of December 20, 2017. The Agency is taking this action to allow interested persons additional time to submit comments.", "2018-03-21", 2018, 3, "https://www.federalregister.gov/documents/2018/03/21/2018-05659/drug-products-labeled-as-homeopathic-draft-guidance-for-staff-and-industry-availability-extension-of", "https://www.govinfo.gov/content/pkg/FR-2018-03-21/pdf/2018-05659.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled \"Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Availability\" that appeared in the...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2018-05659"], "units": {}, "query_ms": 187.4918700195849, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}